Antihypertensive lactams
    1.
    发明授权
    Antihypertensive lactams 失效
    抗高血压内酰胺

    公开(公告)号:US4347246A

    公开(公告)日:1982-08-31

    申请号:US263824

    申请日:1980-05-15

    摘要: A compound of the formula ##STR1## wherein: R.sub.1 is independently lower alkyl having from 1 to 6 carbon atoms, lower alkenyl having from 2 to 6 carbon atoms, lower alkynyl having from 2 to 6 carbon atoms, hydroxy, hydroxyalkyl, alkoxy, thio, thioalkyl, alkylmercapto, amino, aminoalkyl, alkylamino, nitro, cyano, alkanoyl, carboxy, carboxyalkyl, carbalkoxy, carbalkoxyalkyl, halogen, alkylsulfoxy, alkylsulfonyl, sulfonyl, sulfonamido, trifluoromethyl, or methylenedioxy, wherein the alkyl group in hydroxyalkyl, thioalkyl, aminoalkyl, carboxyalkyl, alkoxy, alkylmercapto, alkylsulfoxy, alkanoyl, carbalkoxy, and carbalkoxyalkyl has from 1 to 6 carbon atoms,n is an integer from 1 to 4 inclusive,R.sub.2 is selected from the group consisting of hydrogen and cycloalkyl, wherein the cycloalkyl group contains from 3 to 16 carbon atoms,R.sub.3 and R.sub.4 are hydrogen, andY is oxygen, sulphur, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.The compounds are useful as antihypertensives, and have angiotensin converting enzyme inhibitory activity.

    摘要翻译: 下式化合物其中:R 1独立地为具有1至6个碳原子的低级烷基,具有2至6个碳原子的低级烯基,具有2至6个碳原子的低级炔基,羟基,羟基烷基,烷氧基,硫代 ,烷基巯基,氨基,氨基烷基,烷基氨基,硝基,氰基,烷酰基,羧基,羧基烷基,烷氧基,烷氧基烷基,卤素,烷基磺酰氧基,烷基磺酰基,磺酰基,亚磺酰氨基,三氟甲基或亚甲二氧基,其中羟基烷基, ,羧基烷基,烷氧基,烷基巯基,烷基亚磺酰基,烷酰基,烷氧基和烷氧基烷基具有1至6个碳原子,n是1至4的整数,其中R 2选自氢和环烷基,其中环烷基包含 3至16个碳原子,R3和R4是氢,Y是氧,硫,= NR1,= NOR1或= N-NH2,R1与上述定义相同。 该化合物可用作抗高血压药,并具有血管紧张素转换酶抑制活性。

    Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of
use thereof
    2.
    发明授权
    Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of use thereof 失效
    抗高血压药物1,4-硫氮杂菌素,1,4-噻嗪酮类药物及其应用方法

    公开(公告)号:US4287203A

    公开(公告)日:1981-09-01

    申请号:US142945

    申请日:1980-04-23

    摘要: Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive,R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decanydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronaphthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, andY is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.

    摘要翻译: 结构的抗高血压化合物其中:n为0〜2的整数,R1,R2,R3,R4,R5,R6和R7独立地为氢,具有1-6个碳原子的烷基, 2至6个碳原子,具有2至6个碳原子的炔基,具有3至16个碳原子的环烷基,苯基,苄基,甲苯基,萘基,苯乙基,茚满基,四氢萘基,癸烷基萘基,吡啶基,喹啉基,吡咯烷基,吡咯基,吗啉基, 硫代吗啉基,呋喃基,糠基,四氢糠基,苯并咪唑,噻吩基,亚氨基或四氢吲哚基,其中R 1至R 7基团是烷基,所述基团含有选自羟基,烷氧基,氨基,羧基或烷氧基的取代基,烷氧基 和具有1至6个碳原子的烷氧基,或者R 2与R 3和它们所连接的碳一起为四氢萘基或苯基,当不存在R 1和R 4时,或者R 6和R 7与R 6一起 是attac 和R7连接的氮形成选自吡咯烷基,噻唑烷,四氢 - 异喹啉,硫代吗啉或2,2,5,5-四甲基噻唑烷的杂环,Y = O,= S,= NR1,= NOR1或 = N-NH 2,R 1与上述定义相同。

    Antihypertensive lactams
    3.
    发明授权
    Antihypertensive lactams 失效
    抗高血压内酰胺

    公开(公告)号:US4766210A

    公开(公告)日:1988-08-23

    申请号:US288134

    申请日:1981-07-29

    摘要: Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive,R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decahydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronapthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, andY is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.

    摘要翻译: 结构的抗高血压化合物其中:n为0〜2的整数,R1,R2,R3,R4,R5,R6和R7独立地为氢,具有1-6个碳原子的烷基, 2至6个碳原子,具有2至6个碳原子的炔基,具有3至16个碳原子的环烷基,苯基,苄基,甲苯基,萘基,苯乙基,茚满基,四氢萘基,十氢萘基,吡啶基,喹啉基,吡咯烷基,吡咯基,吗啉基, 硫代吗啉基,呋喃基,糠基,四氢糠基,苯并咪唑,噻吩基,亚氨基或四氢吲哚基,其中R 1至R 7基团是烷基,所述基团含有选自羟基,烷氧基,氨基,羧基或烷氧基的取代基,烷氧基 和具有1至6个碳原子的烷氧基,或者R 2与R 3和它们所连接的碳一起是四氢萘基或苯基,当R 1和R 4不存在时,或者R 6和R 7与R 6一起 附上 并且R 7连接的氮形成选自吡咯烷基,噻唑烷,四氢 - 异喹啉,硫代吗啉或2,2,5,5-四甲基噻唑烷的杂环,Y = O,= S,= NR1,= NOR1或 = N-NH 2,R 1与上述定义相同。

    Cyclic amides
    7.
    发明授权
    Cyclic amides 失效
    循环系统

    公开(公告)号:US5200416A

    公开(公告)日:1993-04-06

    申请号:US148083

    申请日:1980-05-12

    摘要: Compounds of the formula ##STR1## wherein: R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, and R.sub.7 are independently hydrogen or lower alkyl.R.sub.5 is hydrogen, lower alkyl, rad alkanoyl having 1 to 6 carbon atoms.Y is OH or OM wherein M is a pharmaceutically acceptable cation, andn is an integer from 0 to 1, andX.sub.1 and X.sub.2 are independently (CR.sub.8 R.sub.9).sub.mwherein R.sub.8 and R.sub.9 are independently hydrogen or lower alkyl and m is an integer from 1 to 5 are potent angiotensin converting enzyme inhibitors and possess antihypertensive activity.

    摘要翻译: 式的化合物其中:R 1,R 2,R 3,R 4,R 6和R 7独立地是氢或低级烷基。 R5是具有1-6个碳原子的氢,低级烷基,酰基烷酰基。 Y是OH或OM,其中M是药学上可接受的阳离子,n是0-1的整数,X1和X2独立地是(CR8R9)m,其中R8和R9独立地是氢或低级烷基,m是1的整数 至5种是有效的血管紧张素转换酶抑制剂,具有抗高血压活性。